SCHEMBL21283702

SCHEMBL21283702

CCC1(CO)COC2(CC(Cl)C3(CC2Cl)OCC(CC)(CO)CO3)OC1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21283665 0.79 KDM4E (0.32) EPHX1
SCHEMBL21283672 0.79 POLB (0.33) EPHX1
SCHEMBL22562701 0.79
SCHEMBL22562706 0.78 EPHX1 (0.30) EPHX1
SCHEMBL21283701 0.78 EPHX1 (0.30) EPHX1
SCHEMBL21283700 0.78 EPHX1 (0.30) EPHX1
SCHEMBL4815468 0.76 EPHX1 (0.37) EPHX1
SCHEMBL21283677 0.75
SCHEMBL21283678 0.75
SCHEMBL21283698 0.74 EPHX1 (0.39) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725790-B1 MANUFACTURING METHOD FOR DIOL MITSUBISHI GAS CHEMICAL CO (JP) 2022-09-07 EP disclosed
US-20210188864-A1 PRODUCTION METHOD OF DIOL MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-06-24 US disclosed
EP-3530664-B1 DIOL, PROCESS FOR PRODUCING DIOL, DI(METH)ACRYLATE, AND PROCESS FOR PRODUCING DI(METH)ACRYLATE MITSUBISHI GAS CHEMICAL CO (JP) 2020-11-25 EP disclosed
US-10633391-B2 Diol, method for manufacturing diol, di(meth)acrylate, and method for manufacturing di(meth)acrylate MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2020-04-28 US disclosed
WO-2019188114-A1 POLYCARBONATE AND MOLDED BODY 三菱瓦斯化学株式会社 2019-10-03 WO disclosed
US-20190256524-A1 DIOL, METHOD FOR MANUFACTURING DIOL, DI(METH)ACRYLATE, AND METHOD FOR MANUFACTURING DI(METH)ACRYLATE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188864-A1 PRODUCTION METHOD OF DIOL CBR1, CBR3, DECR1 EPHX1 413/4885
US-20190256524-A1 DIOL, METHOD FOR MANUFACTURING DIOL, DI(METH)ACRYLATE, AND METHOD FOR MANUFACTURING DI(METH)ACRYLATE DRD1, ADH1A, DRD2 EPHX1 1780/4885
US-10633391-B2 Diol, method for manufacturing diol, di(meth)acrylate, and method for manufacturing di(meth)acrylate DRD1, ADH1A, DRD2 EPHX1 1780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.